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Perinatal exposure to carcinogens may contribute to the determination ofsusceptibility to cancer in two
situations: a) exposure in utero ofembryonal orfetal somatic cells tocarcinogens, andb) prezygotic exposure
of the germ cells of one or both parents to carcinogens. Epidemiological as well as experimental studies
demonstrate that exposure to carcinogens in utero increases the occurrence of cancer postnatally. Studies
with experimental animals suggest that prezygotic exposure of germ cells to carcinogens can result in an
increased incidence of cancer not only in immediate but also in subsequent generations. Although several
studies suggest a transgeneration effect of carcinogens in human populations, the evidence cannot yet be
considered conclusive. In particular, while some hypotheses can be advanced, the mechanism(s) by which
increased susceptibility or predisposition to cancer may be transmitted via the germ cells has not yet been
clarified. In conjunction with exposure both in utero and prezygotically, it is important to consider postnatal
exposure topossibletumor-promotingagents. Results from experimental animalssuggestthatoncogenes can
be activated transplacentally, and human studies indicate that tumor-suppressor gene inactivation may be
involved in the transgenerational effect ofcarcinogens.
Introduction
It is clear that multiple genetic events are involved in
carcinogenesis, as exemplified in human colon carcino-
genesis (1). The multistage nature of cancer implies that
cells thatcontain one orfewgenetic mutations maybehave
likenormal cells; several othergeneticinsults arerequired
to confer the tumor phenotype. It can thus be suggested
that one or more genetic insults may occurin germ cells or
in somatic cells inutero,which maynotbe expressed until
further genetic events occur in postnatal life (2).
While the concept ofmultistage carcinogenesis and the
multifactorial origins of cancer are well recognized, we
still tend to evaluate carcinogenic risk as ifmost cancers
were related causally to a single agent or a single
exposure. This has also been the case in studies of the
prezygotic or intrauterine effects of carcinogens. Recent
studies suggest, in addition, that postnatal exposure to
tumor-promoting agents plays a crucial role in producing
tumors in animals that were exposed to carcinogens in
utero or the male parents ofwhich were exposed prior to
mating. Prenatal carcinogenic events thus play an impor-
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tant role in determining postnatal susceptibility to car-
cinogens.
Molecular biological studies have shown that specific
tumor-suppressor genes canbe mutated in germ cells and
transmitted to offspring. For example, Rb and p53 genes
were found to be mutated in hereditary retinoblastoma
and Li-Fraumeni syndrome, respectively (3,4). In animal
studies it has been established that mice that have trans-
genic activated oncogenes are prone to cancer (5). While
such information supports the idea of transgenerational
transmission of carcinogenic risk, it is not clear whether
exogenous agents such as environmental carcinogens are
responsible for these risks. We review here available data
on this subject and discuss the possible importance of
postnatal exposure to carcinogens and the molecular
mechanisms ofprenatal carcinogenic events.
Transplacental Initiation and Postnatal
Promotion in Experimental Animals
Transplacental carcinogenic effects of a chemical were
reported as early as 1947. Larsen (6) showed that admin-
istration ofurethane topregnantstrainAmiceresultedin
the accelerated appearance ofmore pulmonary tumors in
offspring. Sincethen,theprenatalcarcinogeniceffectsofa
large number of chemicals of quite different chemical
structures have been demonstrated in several species (7).YAMASAKI ET AL.
The first attempt to amplify the effect of exposure in
utero to a carcinogen by postnatal exposure to another
carcinogen was made by Goerttler et al. (8). After
exposure in utero to 7,12-dimethylbenz[a]anthracene
(DMBA), exposed offspring were painted with a tumor
promoting agent, 12-O-tetradecanoylphorbol 13-acetate
(TPA); an increased number ofskin tumors was induced.
These results were confirmed with other strains of mice
(9,10). The transplacental initiation-postnatal promotion
protocol has also been used in rats and patas monkeys
(11,12). In rats, theincidence offollicularthyroid tumors in
offspring that had been treated in utero with N-methyl-
N-nitrosoureawasincreased afterpostnatalpromotionby
phenobarbital (11). Rice et al. (12) showed in monkeys that
liver tumors could be initiated transplacentally by N-
nitrosodiethylamine and promoted postnatally by phe-
nobarbital.
In humans, diethylstilbestrol and X-rays are known to
be transplacental carcinogens (13,14); however, thereis no
epidemiological evidence thatpostnatal exposure to other
factors enhances tumor incidence in individuals exposed
transplacentally to known carcinogens.
Oncogene Activation by
Transplacental Carcinogenesis
Certain cellular proto-oncogenes are expressed in fetal
tissues atlevels differentfromthoseintheiradultcounter-
parts (15). Thus, it is possible that the vulnerability of
oncogenes to the actions ofexternal agents is different in
fetuses and adults. In orderto examine thispossibility,we
inducedmouseskintumorsbytheprotocol oftransplacen-
talinitiationby DMBAand postnatal treatmentwith TPA
and then analyzed their oncogenes (10). No tumor was
induced if the offspring were not painted with TPA
postnatally, suggesting the DMBA may act merely as an
initiating agent on epidermal cells. In the skin papillomas
and carcinomas, we found the DMBA-specific activation
patternofHa-rasgenes,namelyAtoTtransversion atthe
61st codon. This specific mutation was not observed when
benzo[a]pyrene was used as the transplacental initiating
agent. These results suggested that DMBA induces an
oncogenic mutation in fetal cells that remains dormant
untilthe cells encounter atumor-promoting stimulus during
the postnatal period. Thus, the consequence ofexposure in
uterotocarcinogensmaybegeneticdamageequivalenttoan
initiation event, which may become manifest only after
postnatal exposure to tumor promoting agents.
Oncogene activationintransplacentallyinduced tumors
has also been observed in other studies (16,17). For exam-
ple, rat peripheral nervous system tumors induced trans-
placentallybyN-ethyl-N-nitrosourea containedmutations
ofthe neu oncogene (16). The mutations wereinvariably T
toAtransversions atthe2012th base. Mutation ofthe neu
oncogeneintheperipheralnervous systemintransplacen-
tally induced tumors was also observed using N-methyl-
N-nitrosourea (17): Following transplacental exposure to
this compound, mammary and kidney tumors were pro-
duced, and an Ha-ras G to A transition was found in
mammary and a Ki-ras G to Atransition in kidney tumor
cells (17). These results are compatible with those of
Loktionov et al. (18), who showed that transplacental
exposure to DMBA induced skin, liver, and lung tumors
which contained Ha-ras (skin and liver) orKi-ras (lung)A
to T mutations. It can therefore be suggested that admin-
istration ofa single carcinogen transplacentally produces
tumors in multiple tissues, with specific patterns of
oncogene activation. It is also interesting to note that
tumors induced by prenatal exposure contain similar
oncogene activation patterns as those observed in tumors
induced postnatally by the same carcinogens, suggesting
that fetal and adult cellular proto-oncogenes can be acti-
vated by carcinogens in a similar manner.
Transgenerational Effect of
Carcinogens
Various studies in experimental animals suggest that
the effects of a carcinogen can be transmitted multi-
generationally, either when exposure occurs in utero or
when parents (mostly fathers) are exposed before mating
(2).ThestudiesconductedtodatearesummarizedinTable
1. While most carcinogens are genotoxic, diethylstil-
bestrol, which is not known to induce gene mutations, has
also been shown to be a transgenerational carcinogen in
mice (19). In addition, female offspring of male descend-
ants of diethylstilbestrol-treated mothers mated with
untreated females have a high incidence of uterine sar-
comas and ofbenign tumors ofthe ovary(20). Themolecu-
lar mechanisms of germ-cell transmission of genetic
damage maynotbe limited to mutation; mechanisms such
as genomic imprinting may play an important role (21).
Iransmission of tumor initiation through germ cells
which can be expressed following postnatal exposure to
promoting agents has been reported byseveral authors. A
multigeneration effect of DMBA on skin initiation was
foundbyNapalkov etal. (9) and confirmedbyLoktionov et
al. (22), onlyaftertheoffspringwerepaintedwiththe skin
tumor promoting agent TPA. Two-generation transmis-
sion of skin tumor initiation was recently extended to
X-rays (23). Similarly, Nomura (24) and Vorobotsova and
Kitaev(25)foundthatlargeclustersoflungtumornodules
developed when the offspring ofirradiated parents were
treated postnatallywith urethane.
Some evidence of transgenerational carcinogenesis in
humans comes from an epidemiologic study of radiation
workers near Sellafield in the United Kingdom (26). An
increased rate ofleukemiawas seen amonglocalresidents
under the age of 25 whose fathers were employed in the
nuclear industry. A significant increase was observed in
thechildren offatherswhohadreceived10mSv ormoreof
radiationinthe6monthspriortoconceiving.Theseresults
are in contrast to the negative results found for atomic
bombsurvivors: noexcessofleukemiawas seenamongthe
offspring ofJapanese men who survived the atomic bomb
blasts (27). Several reasons have been offered to explain
the apparentdiscrepancybetweenthe studiesin Sellafield
and in Hiroshima-Nagasaki. Itis importantto emphasize
that only children born to survivors in Hiroshima-
Nagasaki between 1946 and 1982 were studied, and very
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Table 1. Multigenerational effects ofcarcinogens.a
Agent Species (strain) Treatmentb Tumors observed in subsequent generationsb
MCA Rat (Wistar) Mother (before and Various sites
shortly after mating)
OATT Mouse (C3HA) Pregnant mother Liver tumors
DMBA Mouse (Swiss) Pregnant mother Mammary carcinomas, ovarian tumors, lung adenomas, etc.
DMBA Mouse (MCA) Pregnant mother Lung adenomas, ovarian tumors, malignant lymphomas,
etc.
MNU Rat (BDIV) Pregnant mother Kidney tumors, neurogenic tumors, mammary tumors
ENU Rat (BDVI) Father before mating Neurogenic tumors (in F1)
X-rays, ure- Mouse (ICR) Mother or father before mating Lung tumors, ovarian tumors, lymphocytic leukemia (in F1,
thane, 4NQO F2, F3)
DES Mouse (CD-1) Pregnant mother Uterine adenocarcinomas, ovarian tumors
NDEA Hamster Pregnant mother No evidence ofincreased risk in progeny
DMBA Mouse (SHR) Pregnant mother (TPA painted on Fo Skin and various other tumors
and Fj)
X-rays Mouse (SHR) Father before mating (urethane Multiple lung adenomas
treatment in F1)
Father before mating (TPA treatment Skin tumors
in F1 and F2)
OAAT Mouse (CBA) Pregnant mother Liver tumors
BP Mouse (A) Pregnant mother Multiple lung adenomas in Fo, Fl, F2, and F3
ENU Rat (BDIV) Father before mating No clear evidence ofincreased risk in progeny
DES Mouse (CD-1) Pregnant mother Uterine sarcomas and benign ovarian tumors in F1 females
derived from treated male parents mated with untreated
females
Abbreviations: MCA, 3-methylcholanthrene; OAAT, o-aminozaotoluene; DMBA, 7, 12-dimethylbenz[a]anthracene; MNU, N-methylnitrosourea;
ENU, N-ethylnitrosourea; 4NQO, 4-nitroquinoline-1-oxide; NDEA, N-nitrosodiethylamine; DES, diethylstilbestrol; BP, benzo[a]pyrene; TPA, 12-0-
tetradecanoylphorbol 13-acetate.
'Modified from Tomatis et al. (2), in whichindividual references are cited.
bFo generation exposed in utero.
few children were conceived during the first months fol-
lowingtheatomicexplosion. SincethereportofGardneret
al. (26) suggests a high risk for childhood leukemia after
paternal exposure duringthe 6 months before conception,
the difference in the exposure period between Sellafield
and Hiroshima-Nagasaki may have resulted in different
multigenerational effects ofradiation. Itis also important
toemphasize thatGardneretal. studiedmenwhoreceived
chronic exposure to radiation, whereas the atomic bomb
survivors received a single high dose. Assuming that
radiation may act as an initiating agent in germ cells, itis
also important to consider possible differences in postna-
tal exposures to tumorpromoting agents: Theremayhave
been different postnatal risk factors in Hiroshima-
Nagasaki and in Sellafield.
More than 30 studies have been published in which an
association hasbeensoughtbetweenchildhoodcancerand
parental occupation (27,28). The sample sizes in the indi-
vidual studies aregenerallytoo smallforconclusions tobe
reached,anditisdifficulttoaggregatethestudiesbecause
ofdifferent categorizations ofexposures and occupations.
While noclear-cut,positive associationisfoundin anyofthe
studies, some associations with specific occupational
exposures appearmoreoftenthanmightbeexpected.These
include exposures to motor vehicle exhaust, to fumes in
welding, to paints, to pesticides, and in agriculture (28,29).
Molecular Mechanisms in
Transgenerational Carcinogenesis
The results of animal experiments show that car-
cinogens caninduceheritablemutations andchromosomal
translocations in germ cells (30). What kind of genes are
altered in germ cells in order tobring about transgenera-
tional carcinogenesis? While both cellular oncogenes and
tumor suppressor genes may be critical targets of car-
cinogens in somatic cells, recessive tumor suppressor
genes may be the preferred targets in germ cells. The
presence ofmutated oncogenes in germ cells may not be
compatible with the normal process of development. A
recent study by Loktionov et al. (22) indirectly supports
this notion. When mice exposed to DMBA in utero were
painted with TPA postnatally, a high incidence of skin
tumorswasseen,andmostofthetumorscontainedanAto
T transversion atthe 61st codon ofHa-ras-the mutation
oftenfoundinDMBA-inducedtumors.Whenmiceexposed
in utero (FO) were mated and their offspring (F1) painted
with TPA, the increased frequency of skin papillomas
persisted, confirming the transgeneration "initiating"
effect of DMBA. ITmors produced in the F1 generation,
however, did not contain the A to T mutation at the 61st
codon of Ha-ras, suggesting that this mutation is not
responsible for transgenerational carcinogenesis.
Transmission of mutant tumor-suppressor genes
through germ cells hasbeen shown to occurin humans. It
has been proposed thatthe Li-Fraumeni syndrome is due
to a germinal mutation ofthe recessive p53 gene (4) and
thatthehereditaryformofretinoblastomaisduetoapoint
mutation ofthe retinoblastoma gene (3). Since many envi-
ronmentalcarcinogens areknowntoinducemutations,the
transgenerational effects of carcinogens may involve
germ-line mutations of tumor-suppressor genes. Recent
studies suggest that three-quarters of bilateral reti-
noblastomas areduetoclenovomutationingermcells (31).
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De novo germ-cell mutation ofp53genewas alsoreported
in people who developed multiple tumors but did not
express the characteristics ofthe Li-Fraumeni syndrome
(S. H. Friend, personal communication). These results
indicate that germ-cell mutations may continue to occur,
and the question remains as to which carcinogens are
responsible for them.
The molecular mechanisms of transgenerational car-
cinogenesismayinvolvegeneticeventsotherthanclassical
mutations. Prody et al. (32) found amplification of the
cholinesterase gene in two generations of a family sub-
jected to prolonged exposure to organophosphorus insec-
ticides. Since the extentofamplification was similar in the
two generations, the gene amplification could have been
transmitted via the germ line. Genomic imprinting, the
mechanisms of which are largely unknown, may also
influence transgenerational carcinogenesis. DNA meth-
ylation has been associated with genomic imprinting (33).
Agents that alter DNA methylation in germ cells may
induce heritable changes. Ithasbeen suggested, however,
thatthe DNAmethylation pattern is completely erased in
primordial germ cells (34). Thus, if heritable change is
associated with DNA methylation of germ cells, other
genes that govern DNAmethylation must be responsible.
Conclusion
In this review, we have emphasized the importance of
prenatal exposure to carcinogens in atleast some aspects
of genetic predisposition to cancer. While the familial
clustering of cancer cases may be an indicator of an
inherited predisposition to cancer, cases involving new
germ-cell mutations are difficult to detect. Exposure to
carcinogens in utero or preconceptually plays an impor-
tant role in determining susceptibility to postnatal ex-
posure to carcinogens. Prezygotic exposure to a carcino-
gen may be at the origin of a so-called "initiating" event
that is one of many in the sequence of events leading to
neoplasia. The manifestation of such prenatal events
depends on postnatal exposures (10).
It is possible that multiple mutations may accumulate
within afewgenerations andresultinanincreasedriskfor
cancerinthedescendants. Itisequallypossiblethatgerm
cells with multiple mutations do not function as proper
gametes and are not viable. Damage to germ cells is not
limited to mutations; other changes such as gene ampli-
fication and DNAhypomethylation should also be consid-
ered.
In spite of its potential importance, multigenerational
transmission ofcarcinogenic riskhas notyetbeen studied
extensively. Inhumans,thereis nocarcinogenic agentthat
has been shown unequivocally to be a transgenerational
carcinogen. In the past, the necessity ofanalyzing many
samples and offollowingmultiple generations over a long
time hindered progress in this research area. These lim-
itations can nowbecircumvented, atleastpartially, bythe
use of the tools of molecular biology. Further studies in
molecularbiologyshouldhelpinidentifyingenvironmental
carcinogens that may cause transgenerational car-
cinogenesis and the molecular mechanisms involved.
This manuscript was presented at the Conference on Biomonitoring
andSusceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that was held in Kailua-Kona,
Hawaii, 26 October-1 November 1991.
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